Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2014 (2014), Article ID 291382, 3 pages
http://dx.doi.org/10.1155/2014/291382
Case Report

Treatment Resistant Severe Digital Ischemia Associated with Antiphospholipid Syndrome in a Male Patient with Systemic Sclerosis

1Department of Rheumatology, Ankara University Medical Faculty, Sihhiye, 06410 Ankara, Turkey
2Department of Internal Medicine, Ankara University Medical Faculty, Sihhiye, 06410 Ankara, Turkey

Received 22 May 2014; Accepted 27 June 2014; Published 8 July 2014

Academic Editor: Tsai-Ching Hsu

Copyright © 2014 Orhan Küçükşahin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Cervera, J. C. Piette, J. Font et al., “Antiphospholipid syndrome. Clinical and immunologic manifestations and pattern of disease expression in a cohort of 1,000 patients,” Arthritis & Rheumatology, vol. 46, no. 4, pp. 1019–1027, 2002. View at Google Scholar
  2. U. Picillo, S. Migliaresi, M. R. Marcialis, A. M. Ferruzzi, and G. Tirri, “Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis,” Autoimmunity, vol. 20, no. 1, pp. 1–7, 1995. View at Google Scholar · View at Scopus
  3. R. Gupta, M. M. Thabah, S. Gupta, S. Shankar, and A. Kumar, “Clinical significance of antiphospholipid antibodies in Indian scleroderma patients,” Rheumatology International, vol. 30, no. 2, pp. 277–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Minatani, J. Takasaki, H. Iwata, M. Kinoshita, S. Aotsuka, and M. Sumiya, “Acute interstitial pneumonia associated with antiphospholipid syndrome in a patient with systemic sclerosis,” Clinical and Experimental Rheumatology, vol. 18, article 786, no. 6, 2000. View at Google Scholar · View at Scopus
  5. G. Zandman-Goddard, N. Tweezer-Zaks, T. Shalev, Y. Levy, M. Ehrenfeld, and P. Langevitz, “A novel overlap syndrome: systemic sclerosis associated with antiphospholipid syndrome—a case series,” Annals of the New York Academy of Sciences, vol. 1108, pp. 497–504, 2007. View at Google Scholar
  6. W. H. Chun, D. Bang, and S. K. Lee, “Antiphospholipid syndrome associated with progressive systemic sclerosis,” The Journal of Dermatology, vol. 23, no. 5, pp. 347–351, 1996. View at Google Scholar
  7. R. Whittaker, A. Barnett, and P. Ryan, “Antiphospholipid syndrome in scleroderma,” Journal of Rheumatology, vol. 20, no. 9, pp. 1598–1600, 1993. View at Google Scholar · View at Scopus
  8. M. Diallo, S. O. Niang, A. Kane, M. T. Dieng, and B. Ndiaye, “Antiphospholipid antibodies syndrome in dermatology in Dakar: 11 case report,” Dakar Médical, vol. 52, no. 1, pp. 41–45, 2007. View at Google Scholar
  9. E. P. K. Yu, A. J. K. Ostor, and F. C. Hall, “Successful treatment with bosentan for severe digital ischaemia in limited cutaneous systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 66, no. 8, pp. 1122–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Ambach, W. Seo, B. Bonnekoh, and H. Gollnick, “Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase v inhibitor sildenafil,” Journal of the German Society of Dermatology, vol. 7, no. 10, pp. 888–892, 2009. View at Publisher · View at Google Scholar · View at Scopus